Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Corina Plaz Torres

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Alimentary Pharmacology & Therapeutics|March 29, 2019
Editorial: should we abandon HCV genotype testing? MaybeMaria Corina Plaz Torres, Alessio Aghemo
The Lancet. Gastroenterology & Hepatology|December 12, 2018
Direct-acting antivirals for chronic hepatitis C virus genotype 5 and 6 infectionsMaria Corina Plaz Torres, Ana Lleo, Alessio Aghemo
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 11, 2024
Towards an integrated management model for hepatocellular carcinomaEdoardo G Giannini, Giulia Pieri, Maria Corina Plaz Torres
Clinical and Molecular Hepatology|May 3, 2019
Upcoming direct acting antivirals for hepatitis C patients with a prior treatment failureTommaso Lorenzo Parigi, Maria Corina Plaz Torres, Alessio Aghemo
Viruses|July 2, 2021
Management and Treatment of Hepatitis C: Are There Still Unsolved Problems and Unique Populations?Virginia Solitano, Maria Corina Plaz Torres, Nicola Pugliese, et al.
European Journal of Clinical Investigation|February 12, 2025
Effects of glucagon-like PEPTIDE-1 receptor agonists on incidence of hepatocellular carcinoma and liver decompensation in patients with diabetes: A systematic review and META-analysisAndrea Pasta, Antonio Facciorusso, Maria Corina Plaz Torres, et al.
Journal of Hepatology|March 25, 2024
Hepatocellular carcinoma in patients with autoimmune hepatitisAndrea Pasta, Giulia Pieri, Maria Corina Plaz Torres, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 4, 2021
Liver Resection for Patients with Intermediate Stage Hepatocellular Carcinoma: Beyond Rigid Staging Systems Towards a More Personalized Therapeutic ApproachEdoardo G Giannini, Maria Corina Plaz Torres, Alessandro Vitale, et al.
Hepatology (Baltimore, Md.)|March 3, 2022
Diabetes medications and risk of HCCMaria Corina Plaz Torres, Ariel Jaffe, Rachel Perry, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 14, 2020
Risk factors for bleeding following oesophageal band ligation: Providing further evidence to ameliorate clinical practiceEdoardo G Giannini, Giorgia Bodini, Elisa Marabotto, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Alimentary Pharmacology & Therapeutics|March 29, 2019
Editorial: should we abandon HCV genotype testing? MaybeMaria Corina Plaz Torres, Alessio Aghemo
The Lancet. Gastroenterology & Hepatology|December 12, 2018
Direct-acting antivirals for chronic hepatitis C virus genotype 5 and 6 infectionsMaria Corina Plaz Torres, Ana Lleo, Alessio Aghemo
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 11, 2024
Towards an integrated management model for hepatocellular carcinomaEdoardo G Giannini, Giulia Pieri, Maria Corina Plaz Torres
Clinical and Molecular Hepatology|May 3, 2019
Upcoming direct acting antivirals for hepatitis C patients with a prior treatment failureTommaso Lorenzo Parigi, Maria Corina Plaz Torres, Alessio Aghemo
Viruses|July 2, 2021
Management and Treatment of Hepatitis C: Are There Still Unsolved Problems and Unique Populations?Virginia Solitano, Maria Corina Plaz Torres, Nicola Pugliese, et al.
European Journal of Clinical Investigation|February 12, 2025
Effects of glucagon-like PEPTIDE-1 receptor agonists on incidence of hepatocellular carcinoma and liver decompensation in patients with diabetes: A systematic review and META-analysisAndrea Pasta, Antonio Facciorusso, Maria Corina Plaz Torres, et al.
Journal of Hepatology|March 25, 2024
Hepatocellular carcinoma in patients with autoimmune hepatitisAndrea Pasta, Giulia Pieri, Maria Corina Plaz Torres, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 4, 2021
Liver Resection for Patients with Intermediate Stage Hepatocellular Carcinoma: Beyond Rigid Staging Systems Towards a More Personalized Therapeutic ApproachEdoardo G Giannini, Maria Corina Plaz Torres, Alessandro Vitale, et al.
Hepatology (Baltimore, Md.)|March 3, 2022
Diabetes medications and risk of HCCMaria Corina Plaz Torres, Ariel Jaffe, Rachel Perry, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 14, 2020
Risk factors for bleeding following oesophageal band ligation: Providing further evidence to ameliorate clinical practiceEdoardo G Giannini, Giorgia Bodini, Elisa Marabotto, et al.
Pageof 4